0.536
price up icon6.60%   0.033
after-market After Hours: .52 -0.016 -2.99%
loading
VolitionRX Ltd stock is traded at $0.536, with a volume of 437.19K. It is up +6.60% in the last 24 hours and up +12.88% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.503
Open:
$0.4996
24h Volume:
437.19K
Relative Volume:
1.94
Market Cap:
$54.36M
Revenue:
$1.29M
Net Income/Loss:
$-29.87M
P/E Ratio:
-1.4889
EPS:
-0.36
Net Cash Flow:
$-14.70M
1W Performance:
+4.02%
1M Performance:
+12.88%
6M Performance:
-17.46%
1Y Performance:
-24.02%
1-Day Range:
Value
$0.4996
$0.57
1-Week Range:
Value
$0.475
$0.57
52-Week Range:
Value
$0.3951
$0.90

VolitionRX Ltd Stock (VNRX) Company Profile

Name
Name
VolitionRX Ltd
Name
Phone
646 650 1351
Name
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Name
Employee
37
Name
Twitter
@VolitionRx
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
VNRX's Discussions on Twitter

Compare VNRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
VNRX
VolitionRX Ltd
0.5277 49.91M 1.29M -29.87M -14.70M -0.36
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
396.45 152.34B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.27 135.39B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
514.81 41.54B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.07 31.59B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
139.06 24.31B 15.50B 1.33B 2.16B 7.34

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-08-25 Initiated H.C. Wainwright Buy
Feb-01-23 Downgrade The Benchmark Company Buy → Hold
Feb-17-22 Resumed Cantor Fitzgerald Overweight
Mar-10-21 Initiated Cantor Fitzgerald Overweight
May-16-18 Initiated Maxim Group Buy
May-14-18 Reiterated The Benchmark Company Buy
Sep-07-16 Reiterated Rodman & Renshaw Buy
Feb-01-16 Initiated Rodman & Renshaw Buy
View All

VolitionRX Ltd Stock (VNRX) Latest News

pulisher
May 27, 2025

VNRX: Management’s key financial goal for 2025 is to be cash neutral on a full year basis. Four operational milestones have been achieved thus far in 2025. Primary operational goal is to enter into multiple licensing agreements for human diagnostic applicati - Yahoo Finance

May 27, 2025
pulisher
May 20, 2025

VolitionRx Limited (AMEX:VNRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

VolitionRX Ltd. Earnings Call Reveals Promising Growth - TipRanks

May 19, 2025
pulisher
May 19, 2025

VolitionRX shares hold as Benchmark maintains rating - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

VNRX stock touches 52-week low at $0.42 amid market challenges - Investing.com Canada

May 19, 2025
pulisher
May 19, 2025

VolitionRX shares hold as Benchmark maintains rating By Investing.com - Investing.com India

May 19, 2025
pulisher
May 19, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats By Investing.com - Investing.com Canada

May 19, 2025
pulisher
May 17, 2025

VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones - Yahoo Finance

May 17, 2025
pulisher
May 17, 2025

VolitionRx Reports Strong Q1 2025 Performance - TipRanks

May 17, 2025
pulisher
May 16, 2025

VolitionRX (VNRX) Sees Revenue Growth and Cost Reduction in Q1 2 - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Transcript : VolitionRx Limited, Q1 2025 Earnings Call, May 16, 2025 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast - Investing.com

May 16, 2025
pulisher
May 16, 2025

Volitionrx Ltd earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

May 16, 2025
pulisher
May 16, 2025

VolitionRX: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

VolitionRx Q1 2025 Earnings Call Transcript - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Volitionrx Ltd earnings missed by $0.03, revenue fell short of estimates - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

VolitionRx reports Q1 revenue $0.25M, consensus $1.08M - TipRanks

May 15, 2025
pulisher
May 15, 2025

Volition (VNRX) Targets Diagnostic Market Expansion with Nu.Q Platform | VNRX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

VolitionRX Ltd Reports Q1 2025 Revenue of $0.25 Million, Missing - GuruFocus

May 15, 2025
pulisher
May 15, 2025

VolitionRX Ltd (VNRX) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus

May 15, 2025
pulisher
May 12, 2025

VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update - Yahoo Finance

May 12, 2025
pulisher
May 10, 2025

VolitionRx (VNRX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock - Barchart.com

May 09, 2025
pulisher
May 07, 2025

VolitionRx Updates Progress Of Nu.Q NETs Test Adoption - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX) - Defense World

May 07, 2025
pulisher
Apr 29, 2025

VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets - Yahoo Finance

Apr 29, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 23, 2025

VolitionRx enters new sales agreement, terminates old one - Investing.com Australia

Apr 23, 2025
pulisher
Apr 22, 2025

VolitionRx enters new sales agreement, terminates old one By Investing.com - Investing.com South Africa

Apr 22, 2025
pulisher
Apr 18, 2025

VolitionRX Ltd (AMEX: VNRX): An Enticing Stock To Watch - stocksregister.com

Apr 18, 2025
pulisher
Apr 18, 2025

Insider Buying: Reynolds Cameron John, VolitionRX Ltd [VNRX] President and CEO invested 181,818 shares - knoxdaily.com

Apr 18, 2025
pulisher
Apr 14, 2025

VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - The AM Reporter

Apr 14, 2025
pulisher
Apr 11, 2025

H.C. Wainwright maintains buy on VolitionRX with $2.50 target By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 10, 2025

VolitionRx (NYSE:VNRX) Coverage Initiated at HC Wainwright - The AM Reporter

Apr 10, 2025
pulisher
Apr 10, 2025

What is HC Wainwright’s Estimate for VolitionRx Q1 Earnings? - Defense World

Apr 10, 2025
pulisher
Apr 10, 2025

VolitionRX stock holds as Benchmark maintains rating - Investing.com Australia

Apr 10, 2025
pulisher
Apr 09, 2025

VolitionRx (NYSE:VNRX) Now Covered by Analysts at HC Wainwright - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

VolitionRX stock holds as Benchmark maintains rating By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

HC Wainwright Initiates VolitionRx With Buy Rating, $2.50 Price Target - marketscreener.com

Apr 08, 2025
pulisher
Apr 05, 2025

VolitionRx (NYSE:VNRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

VolitionRx Moves to Register Warrant Shares on New Form By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

VolitionRx Moves to Register Warrant Shares on New Form - Investing.com

Apr 04, 2025

VolitionRX Ltd Stock (VNRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$174.46
price up icon 0.64%
diagnostics_research WAT
$343.98
price down icon 1.51%
diagnostics_research LH
$246.59
price down icon 1.03%
$158.47
price up icon 0.52%
diagnostics_research MTD
$1,138.41
price down icon 1.54%
diagnostics_research IQV
$139.15
price down icon 0.86%
Cap:     |  Volume (24h):